Pacira BioSciences' Cash from Financing Activities fell 895012.3% to -$257.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$319.9 million, marking a year-over-year decrease of 192410.63%. This contributed to the annual value of $17.4 million for FY2024, which is 10948.64% up from last year.
Pacira BioSciences' Cash from Financing Activities amounted to -$257.5 million in Q3 2025, which was down 895012.3% from -$57.5 million recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Cash from Financing Activities registered a high of $361.4 million during Q4 2021, and its lowest value of -$257.5 million during Q3 2025.
In the last 5 years, Pacira BioSciences' Cash from Financing Activities had a median value of -$2.8 million in 2024 and averaged -$26.6 million.
In the last 5 years, Pacira BioSciences' Cash from Financing Activities surged by 557727.27% in 2024 and then tumbled by 895012.3% in 2025.
Over the past 5 years, Pacira BioSciences' Cash from Financing Activities (Quarter) stood at $361.4 million in 2021, then crashed by 116.19% to -$58.5 million in 2022, then soared by 96.96% to -$1.8 million in 2023, then dropped by 9.89% to -$2.0 million in 2024, then tumbled by 13070.13% to -$257.5 million in 2025.
Its Cash from Financing Activities was -$257.5 million in Q3 2025, compared to -$57.5 million in Q2 2025 and -$3.0 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value